Reliance Jio Says No Charges For Calling Non-Jio Numbers Until Existing Plan Expires
Reliance Jio on Thursday said that customers who recharged their numbers on or before October 9 will continue to get free call benefits. "If you have recharged on or before October 9, you can continue enjoying free call benefits (even to non-Jio members), until your plan expires," the telecom operator mentioned in a tweet. On Wednesday, Jio announced that it will charge 6 paise per minute for calls made to other network operators in line with the Interconnect Usage Charge or IUC fixed by the telecom regulator Telecom Regulatory Authority of India (TRAI). This is for the first time that users will have to pay for making a phone call from Jio.
An important update for all Jio users. pic.twitter.com/TR04y92wmC
October 10, 2019This means that customers who have recharged their numbers with any plan of the operator by October 9 will not have to pay any additional charges for making calls to other networks until their next recharge.
Jio said that IUC charges will not be applicable on calls made by Jio users to other Jio numbers and to landline phones and calls made using WhatsApp, FaceTime and other such platforms. Incoming calls from all networks will also continue to be free. However, Jio's postpaid customers will be charged for voice calls at the rate of 6 paise per minute.Â
The telecom operator had earlier assured that calls made to other mobile operators will be charged at the prevailing IUC rate of 6 paise per minute through IUC top-up vouchers till such time that TRAI moves to zero termination charge regime.
Jio's IUC top-up vouchers are priced between Rs 10 and Rs 100, according to a company statement. These plans offer certain IUC minutes and additional data.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.